Cue Health Inc.
HLTHQ Healthcare Health Information Services
Cue Health Inc.’s revenue for fiscal 2023 (year ended December 2023) was $70.9 million, down 85.3% from fiscal 2022.
Follow HLTHQ
Cue Health Inc. (HLTHQ) Piotroski F-score
Cue Health Inc.'s Piotroski F-score for fiscal 2023 is 2 out of 9: 2 of nine tests of profitability, leverage and efficiency passed, down from 3 in fiscal 2022.
Piotroski F-score, annual
Embed this chart
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|---|---|
| FY2023 | 2 | (1.00) |
| FY2022 | 3 | — |
How fiscal 2023’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | (72.21%) | (23.74%) | Fail | 0 |
| Positive operating cash flow | (137.81m) | (111.92m) | Fail | 0 |
| Rising return on assets | (72.21%) | (23.74%) | Fail | 0 |
| Cash flow above net income | 235.65m | 82.14m | Pass | 1 |
| Falling long-term leverage | 0.00 | 0.00 | Pass | 1 |
| Rising current ratio | 2.54 | 5.21 | Fail | 0 |
| No new shares issued | 152,877,300 | 148,024,700 | Fail | 0 |
| Rising gross margin | (79.16%) | 31.75% | Fail | 0 |
| Rising asset turnover | 0.14 | 0.59 | Fail | 0 |
| Piotroski F-score | Weak — most fundamentals deteriorated | 2 | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| ACON Aclarion, Inc. compare | 5 |
| RNLXY Renalytix plc - Sponsored ADR compare | 4 |
| VSEED VSee Health, Inc. compare | 4 |
| ZCMD Zhongchao Inc. compare | 3 |
| MGRX Mangoceuticals, Inc. compare | 3 |
| HLTHQ Cue Health Inc. | 2 |
| ETAOF ETAO International Co., Ltd. compare | — |
| BFRG Bullfrog AI Holdings Inc. compare | — |
| HCTI Healthcare Triangle, Inc. compare | — |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover